STOCK TITAN

Precision Optics Announces the Receipt of a New Production Order for Robotic Laparoscopy System

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced an $890,000 initial production order for a complex imaging sub-assembly for a new robotic laparoscopy system. The order is expected to be delivered between January and October 2024, with potential for follow-on orders depending on market acceptance. This development is anticipated to drive revenue growth and recovery in the second half of the fiscal year.
Positive
  • The receipt of the $890,000 initial production order indicates a positive development for Precision Optics, demonstrating confidence from customers in the company's advanced optical instruments. The potential for follow-on orders and revenue acceleration in the second half of the fiscal year indicates a positive outlook for the company's financial performance.
Negative
  • None.

GARDNER, Mass., Nov. 9, 2023 /PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the receipt of an $890,000 initial production order for a complex imaging sub-assembly that will be used in the customer's new robotic laparoscopy system. The imaging subassembly incorporates cutting edge optical, electronic and mechanical systems designed by Precision Optics.

The program with this customer initially started with engineers at Lighthouse Imaging Corp. and then (following our Lighthouse acquisition) work through the development pipeline to commercial production was performed by our combined engineering team. This initial production order is expected to be delivered between January and October 2024 with follow on production orders expected; the timing and volume of orders ultimately depends on end market acceptance of the system.

"Precision Optics continues to be at the forefront of the development of highly integrated endoscopy systems that help our clients bring innovative new surgical solutions to the market," commented Dr. Joe Forkey, CEO of Precision Optics. "The Precision Optics and Lighthouse team has worked closely with this customer for a number of years, and we are extremely pleased to have the program transition from our engineering pipeline to production. This program will be a key driver of the anticipated recovery from lower first quarter revenue and acceleration of quarterly revenue in the second half of this fiscal year. We look forward to working closely with this customer in the years to come to fulfill their commercial production needs."

About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and 3D imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division's electronic imaging expertise and its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com

About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements which express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company's future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by the Company's management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in the Company's annual report on Form 10-K and in other documents we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement, except as required by law.

Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800

Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/precision-optics-announces-the-receipt-of-a-new-production-order-for-robotic-laparoscopy-system-301982682.html

SOURCE Precision Optics Corporation

FAQ

What did Precision Optics announce?

Precision Optics Corporation, Inc. (NASDAQ: POCI) announced an $890,000 initial production order for a complex imaging sub-assembly for a new robotic laparoscopy system.

When is the order expected to be delivered?

The order is expected to be delivered between January and October 2024.

What is the potential for follow-on orders?

Follow-on production orders are expected, depending on end market acceptance of the system.

Who commented on the announcement?

Dr. Joe Forkey, CEO of Precision Optics, commented on the announcement, expressing optimism about the program's impact on the company's revenue and future collaboration with the customer.

What is the anticipated impact of the program on revenue?

The program is expected to drive revenue growth and recovery in the second half of the fiscal year for Precision Optics.

Precision Optics Corporation, Inc.

NASDAQ:POCI

POCI Rankings

POCI Latest News

POCI Stock Data

32.74M
4.85M
24.86%
32.15%
0.07%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
GARDNER